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Abstract
The biosynthesis of membrane lipids is an essential pathway for virtually all bacteria. Despite its potential importance for the
development of novel antibiotics, little is known about the underlying signaling mechanisms that allow bacteria to control
their membrane lipid composition within narrow limits. Recent studies disclosed an elaborate feed-forward system that
senses the levels of malonyl-CoA and modulates the transcription of genes that mediate fatty acid and phospholipid
synthesis in many Gram-positive bacteria including several human pathogens. A key component of this network is FapR, a
transcriptional regulator that binds malonyl-CoA, but whose mode of action remains enigmatic. We report here the crystal
structures of FapR from Staphylococcus aureus (SaFapR) in three relevant states of its regulation cycle. The repressor-DNA
complex reveals that the operator binds two SaFapR homodimers with different affinities, involving sequence-specific
contacts from the helix-turn-helix motifs to the major and minor grooves of DNA. In contrast with the elongated
conformation observed for the DNA-bound FapR homodimer, binding of malonyl-CoA stabilizes a different, more compact,
quaternary arrangement of the repressor, in which the two DNA-binding domains are attached to either side of the central
thioesterase-like domain, resulting in a non-productive overall conformation that precludes DNA binding. The structural
transition between the DNA-bound and malonyl-CoA-bound states of SaFapR involves substantial changes and large
(.30 A˚) inter-domain movements; however, both conformational states can be populated by the ligand-free repressor
species, as confirmed by the structure of SaFapR in two distinct crystal forms. Disruption of the ability of SaFapR to monitor
malonyl-CoA compromises cell growth, revealing the essentiality of membrane lipid homeostasis for S. aureus survival and
uncovering novel opportunities for the development of antibiotics against this major human pathogen.
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Introduction
The cell membrane is an essential structure to bacteria. It
primarily consists of a fluid phospholipid bilayer in which a
variety of proteins are embedded. Most steps involved in
phospholipid biosynthesis are therefore explored as targets for
designing new antibacterial drugs [1]. The central events in the
building of phospholipids enclose the biosynthesis of fatty
acids, which are the most energetically expensive lipid
components, by the type II fatty acid synthase (FASII) on the
cytoplasmic side of the membrane, and subsequent delivery of
the latter to the membrane-bound glycerol-phosphate acyl-
transferases (Fig. S1). Due to the vital role of the membrane
lipid bilayer, bacteria have evolved sophisticated mechanisms
to finely control the expression of the genes responsible for the
metabolism of phospholipids [2].
Transcriptional regulation of bacterial lipid biosynthetic genes is
poorly understood at the molecular level. Indeed, the only two
well-documented examples are probably those of the transcription
factors FadR and DesT, which regulate the biosynthesis of
unsaturated fatty acids (UFA) in Escherichia coli and Pseudomonas
aeruginosa, respectively. FadR was discovered as a repressor of the
b-oxidation regulon [3,4] and subsequently found to also activate
the transcription of fabA and fabB, two essential genes for the
biosynthesis of UFA [5–7]. Binding of FadR to its DNA operator is
antagonized by different long-chain acyl- CoAs [8–11], in
agreement with the proposed structural model [12–14]. DesT is
a TetR-like repressor that primarily controls the expression of the
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desCB operon, which encodes the components of an oxidative fatty
acid desaturase, and secondarily controls the expression of the
fabAB operon of Pseudomonas aeruginosa [15]. DesT binds either
saturated or unsaturated acyl-CoAs, which respectively prevent or
enhance its DNA-binding properties [16], thus allowing the
repressor to differentially respond to alternate ligand shapes [17].
Among the known regulatory mechanisms that control lipid
synthesis in bacteria, the Bacillus subtilis Fap system is unique in
that the regulated final products, fatty acids and phospholipids, are
controlled by a metabolite required at the beginning of the fatty
acid biosynthetic pathway, malonyl-CoA [18,19]. To monitor the
levels of this metabolite, bacteria employ the FapR protein [20],
which is highly conserved among several Gram-positive patho-
gens. FapR has been shown to globally repress the expression of
the genes from the fap regulon (Fig. S1) encoding the soluble FASII
system as well as two key enzymes that interface this pathway with
the synthesis of phospholipid molecules [18].
Like most transcriptional regulators in bacteria, FapR is a
homodimeric repressor [20]. Each protomer consists of a N-
terminal DNA-binding domain (DBD) harboring a classical helix-
turn-helix motif connected through a linker a-helix (aL) to a C-
terminal effector-binding domain (EBD). We have previously
determined the structure of a truncated form of FapR from Bacillus
subtilis (BsFapR), which included the linker a-helix and the EBD
but lacked the DBD [20]. The EBD folds into a symmetric dimer
displaying a ‘hot-dog’ architecture, with two central a-helices
surrounded by an extended twelve-stranded b-sheet. A similar fold
has been found in many homodimeric acyl-CoA-binding enzymes
[21,22] involved in fatty acid biosynthesis and metabolism [23,24].
However, the bacterial transcriptional regulator FapR appears to
be so far the only well-characterized protein family to have
recruited the ‘hot-dog’ fold for a non-enzymatic function.
The structure of truncated FapR bound to malonyl-CoA
revealed structural changes in some ligand-binding loops of the
EBD, and it was suggested that these changes could propagate to
the missing DNA-binding domains to impair their productive
association for DNA binding [20]. However, the actual
mechanisms involved remain largely unknown in the absence of
detailed structural information of the full-length repressor and its
complex with DNA. Here, we report the structural characteriza-
tion of full-length FapR from Staphylococcus aureus (SaFapR), a major
Gram-positive pathogen causing severe human infections [25–27].
The crystal structures of SaFapR have been obtained for the
protein alone and for the complexes with the cognate DNA
operator and the effector molecule, malonyl-CoA, providing
important mechanistic insights into the mode of action of this
transcriptional regulator. We further demonstrate that structure-
based SaFapR mutants interfering with malonyl-CoA binding are
lethal for S. aureus. These data show that membrane lipid
homeostasis is essential for S. aureus survival and highlights this
regulatory mechanism as an attractive target to develop new
antibiotics.
Results
FapR senses malonyl-CoA and regulates lipid
biosynthesis in S. aureus
The S. aureus fap regulon is organized as in B. subtilis [18], except
for two missing genes (yhfC and fabHB) (Table S1). Electrophoretic
mobility shift assays revealed that SaFapR binds to its own
promoter (PfapR) and that malonyl-CoA specifically disrupts the
repressor-operator complex (Fig. S2). Furthermore, the unlinked
genes plsX and fabH from the fap regulon are upregulated in two
distinct S. aureus strains lacking the repressor (Fig. S3A) and
SaFapR is able to complement a B. subtilis fapR mutant strain (Fig.
S3B). These results clearly demonstrate that SaFapR conserves the
same regulatory function originally described for the B. subtilis
orthologue [20].
The SaFapR-DNA complex
The crystal structure of SaFapR in complex with a 40-bp
oligonucleotide comprising the PfapR promoter was determined at
3.15 A˚ resolution (Table 1). Two SaFapR homodimers were
observed to bind to a single DNA molecule in the crystal (Fig. 1A).
This observation is in agreement with isothermal titration
calorimetry (ITC) studies of protein-DNA interactions, which
showed a complex isotherm with a large exothermic component
and two distinct binding reactions (Fig. 1B). Sequence analysis of
the promoters of the fap regulon from B. subtilis [18] and S. aureus
(Fig. S4) revealed the presence of a conserved inverted repeat. Our
previous DNAse I footprinting analyses performed with BsFapR
on both strands of the B. subtilis fapR promoter demonstrated that
this symmetric element covers half of the DNAse protected region
[20]. Interestingly, this region corresponds to the recognition site
of one SaFapR homodimer in the crystal, suggesting a sequential
mechanism of binding. Indeed, a sequential binding model fits well
the observed isotherm (Fig. 1B), indicating that the two SaFapR
homodimers bind the operator with nanomolar dissociation
constants of 0.560.1 nM for the first and 5168 nM for the
second binding reactions. In the crystal structure of the complex,
however, the two SaFapR homodimers are related by a local two-
fold symmetry axis, and the DNA molecule is bound in a 50:50
orientation, as confirmed by determining the crystal structure of
SaFapR in complex with an asymmetrically Br-labelled oligonu-
cleotide using the Br anomalous scattering signal (data not shown).
Each protein homodimer exhibits an elongated asymmetric
conformation in the crystal structure, in which the two DNA-
bound DBDs are structurally detached from the central dimeric
‘hot-dog’ EBD. Indeed, the positioning of the EBD (stabilized by
crystal packing contacts) relative to the DBD-DNA complex
requires partial unwinding of the C-terminal end of aL, as
Author Summary
An opportunistic Gram-positive pathogen, Staphylococcus
aureus is a major threat to humans and animals, being
responsible for a variety of infections ranging from mild
superficial to severe infections such as infective endocar-
ditis, septic arthritis, osteomyelitis and sepsis. The increas-
ing resistance of S. aureus against most current antibiotics
emphasizes the need to develop new approaches to
control this important pathogen. The lipid biosynthetic
pathway is one appealing target actively pursued to
develop anti-Staphylococcal agents. Despite its potential
biomedical importance, however, little is known about the
signaling mechanisms that allow S. aureus to control its
phospholipid content. In order to shed light on this
fundamental mechanism, we studied S. aureus FapR
(SaFapR) a transcription factor that senses the levels of
malonyl-CoA, a key intermediate in fatty acid biosynthesis,
and modulates the expression of genes involved in fatty
acid and phospholipid biosynthesis. Our studies of SaFapR
uncovered the mechanistic basis of a complex biological
switch that controls membrane lipid homeostasis in S.
aureus. We also discovered that disruption of the ability of
SaFapR to recognize malonyl-CoA, the ligand that controls
SaFapR binding to DNA, compromises S. aureus viability,
thus revealing new opportunities for the development of
antibiotics against this major human pathogen.
Structure of the Transcriptional Regulator FapR
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confirmed by comparing the structures of the ligand-free and
DNA-bound forms of SaFapR (see below). The amphipatic linker
helix aL plays a major role in stabilizing the molecular architecture
of the SaFapR-DNA complex. Helix aL interacts with aL9 from the
second protomer mainly through its exposed hydrophobic face
(including residues Ile59, Val62 and Ala63; Fig. S5A). This
dimerization region is further stabilized by hydrophobic contacts
(Phe26) and hydrophilic interactions between aL and the a1–a2
connecting loop from both DBDs. In addition, the guanidinium
group of Arg59 gets engaged in electrostatic interactions with the
main-chain carbonyl groups of Pro25 and Ile27, and the hydroxyl
group of Tyr67 is within hydrogen bonding distance to the main-
chain of Ser23 at the end of a19 on the second protomer (Fig.
S5A). Altogether this contact network largely contributes to the
correct relative positioning of the two helix-turn-helix motifs on
the DNA major groove.
The two DBDs from the asymmetric homodimer interact in a
similar manner with DNA. The recognition helix a3 from the
helix-turn-helix motif penetrates the double-helix major groove
and makes extensive interactions with the two DNA chains
(Fig. 2A). The SaFapR-DNA interface mainly involves the DNA
backbone phosphates (Fig. 2B), except for base-specific interac-
tions of Gln41 (from the recognition helix a3) in the major groove
and Arg56 (from the linker helix aL) in the minor groove.
Importantly, the insertion of the guanidinium groups of this
arginine from both protomers promotes the opening of the minor
groove, inducing a pronounced local bending of DNA (Fig. 2C).
The two phosphate-contacting residues from helix a1 (Lys10 and
Arg13), as well as residues from the recognition helix a3 and the
C-terminal half of the linker helix aL (which include most other
DNA-contacting residues) are highly conserved in the entire FapR
protein family (Fig. S6), indicating a conserved mode of DNA-
binding. The N-terminus of the protein (preceding helix a1) faces
the adjacent minor groove in the crystal structure (Fig. 2A),
suggesting that it could be engaged in additional DNA interac-
tions. However, this region is poorly conserved in the FapR
protein family and is disordered in the crystal structure.
Structure of the repressor-effector complex
The crystal structure of full-length SaFapR in complex with
malonyl-CoA, determined at 1.9 A˚ resolution (Table 1),
revealed a different, more compact conformation of the
repressor. Most notably, the two amphipatic linker helices
aL, instead of interacting with each other as in the DNA-bound
repressor, now bind to either side of the central dimeric EBD
(Fig. 3A). This results in a protein conformation with the two
Table 1. Data collection, phasing and refinement statistics.
SaFapR-DNA SaFapR-malonyl-CoA SaFapR (form 1) SaFapR (form 2)
Data collection
Space group C2221 P21 H32 P3121
Cell dimensions
a, b, c (A˚) 114.69, 249.94, 179.21 53.38, 68.5, 61.16 116.58, 116.58, 123.23 110.52, 110.52, 115.11
a, b, c (u) 90, 90, 90 90, 111.3, 90 90, 90, 120 90, 90, 120
Resolution (A˚) 35-3.15 (3.32-3.15) 44-1.9 (2-1.9) 47-2.4 (2.53-2.4) 48-2.6 (2.74-2.6)
Rsym or Rmerge 0.099 (0.572) 0.043 (0.349) 0.060 (0.634) 0.061 (0.426)
I/sI 24.3 (2.4) 16.4 (3.6) 15.6 (2.5) 16.7 (3.4)
Completeness (%) 98.2 (93.7) 99.3 (100) 99.9 (100) 99.7 (98.5)
Redundancy 16.0 (4.9) 3.7 (3.7) 5.5 (5.6) 3.7 (3.6)
Refinement
Resolution (A˚) 3.15 1.9 2.4 2.6
No. reflections 41820 30557 12145 24146
Rwork/Rfree 0.186/0.201 0.198/0.235 0.196/0.246 0.185/0.211
No. atoms
Protein 6040 2538 1460 2431
Ligand/ion 1634 98 25 9
Water - 150 20 52
B-factors
Protein 104 42 63 47
Ligand/Ion 149 41 67 57
Water - 28 34 18
Ramachandran outliers1 (%) 0.5 0 0 0
Ramachandran favored1 (%) 95.8 98.1 97.8 97.0
R.m.s. deviations
Bond lengths (A˚) 0.007 0.012 0.012 0.017
Bond angles (u) 1.14 1.39 1.64 1.61
Values in parentheses are for highest-resolution shell.
1According to the MolProbity server [53].
doi:10.1371/journal.ppat.1003108.t001
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helix-turn-helix domains far apart from each other, corre-
sponding to an incompetent DNA-binding state. Interactions
of helix aL with the lateral face of the EBD play a major role in
stabilizing the observed quaternary organization of the protein,
mainly through extended hydrophobic contacts between
aliphatic and aromatic side chains (Fig. 3B). In addition,
several hydrogen bonding and salt bridge interactions (Fig.
S5B) lock a well-defined structure for the loop connecting helix
aL to the first b-strand of the EBD (residues 70–82), which
further restrict the mobility of aL and contrasts with the loose
asymmetric conformation observed for this loop in the DNA-
bound SaFapR homodimer (Fig. 1A).
The phosphopantetheine and malonyl groups of malonyl-CoA
are well defined in the electron density map (Fig. 3C). The
phosphopantetheine group binds within a tunnel at the interface
between the two protomers in the SaFapR homodimer, and adopts
the same conformation as observed in many acyl-CoA-binding
proteins displaying the hot-dog fold [20,24]. This binding mode
results in the complete occlusion of the ligand malonate from the
bulk solvent. The charged carboxylate group of malonate is
Figure 1. Overall structure of the SaFapR-operator complex. (A) Surface representation of the DNA operator (in red) with two bound FapR
homodimers looking down the non-crystallographic two-fold symmetry axis. For one homodimeric repressor (in yellow and orange) the DNA-binding
domains (DBDs), the linker helix aL and the dimeric effector-binding domain (DBD) are indicated. (B) ITC study of SaFapR binding to the PfapR
operator at 25uC. The top panel shows the raw heat signal for 6 ml injections of a 68 mM solution of SaFapR dimer into a 4 mM solution of the 40 bp
DNA oligonucleotide (curve 1 obtained by subtraction of the SaFapR dilution energy curve 3 from the raw titration curve 2). The bottom panel shows
the integrated injection heats after normalization fitted with a sequential binding model. Two SaFapR dimers bind the operator, with parameters
(Kd,I = 0.560.1 nM, DHuI =222.560.2 kcal/mol, TDSuI =29.860.2, kcal/mol) and (Kd,II = 5168 nM, DHuII =26.9560.2 kcal/mol, TDSuII = 3.060.3 kcal/
mol).
doi:10.1371/journal.ppat.1003108.g001
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neutralized through a salt bridge with the guanidinium side-chain
of Arg110, and makes additional hydrogen bonding interactions
with the main-chain nitrogen from Gly111 and the side-chain of
Asn1199 from the second protomer (Fig. 3C). The engagement of
Arg110 in malonyl-CoA-binding triggers a local reorganization of
hydrogen-bonding interactions (Fig. S5B) and surface reshaping
that further stabilize the loop connecting aL to the first b-strand of
the hot-dog fold in the non-productive conformation (Fig. 3A),
thus preventing DNA binding. On the other hand, the adenosine
39-phosphate moiety of malonyl-CoA is largely exposed to the
solvent (it is partially disordered in one of the two protomers) and
makes no specific contacts with the protein. This implies that
SaFapR specifically recognizes the malonyl-phosphopantetheine
moiety of the ligand, in agreement with the observation that either
malonyl-CoA or malonyl-acyl carrier protein (malonyl-ACP) can
indistinctly function as effector molecules [28].
A detailed comparison of the malonyl-CoA complexes between
full-length SaFapR and the truncated form of BsFapR (lacking the
DBDs) revealed a conserved structural arrangement of the EBD
core, and ligand binding promoted the same conformation of the
connecting loop aL-b1 (Fig. S7). On the other hand, helix aL
displays a different organization, due in part to the absence of the
DBDs. This helix protrudes away from the EBD core in BsFapR to
get involved in crystal packing contacts [20]. Interestingly,
hydrophobic residues engaged in these inter-domain interactions
are largely invariant in the whole FapR family (Fig. S6), as are also
key residues involved in electrostatic interactions (Fig. S5).
Altogether, the structural alignment indicates not only an identical
mode of malonyl-CoA binding but also the conservation of the
DBD – aL – EBD interactions required to stabilize the FapR-
malonyl-CoA complex as visualized in the SaFapR model.
The overall structure of SaFapR
The crystal structure of full-length SaFapR in the absence of
ligands has been obtained in two different crystal forms (Table 1).
Interestingly, in three out of four crystallographically independent
protomers the repressor has the same non-productive quaternary
arrangement as observed in the structure of malonyl-CoA-bound
SaFapR, with helix aL bound to the lateral face of the EBD
(Fig. 4A), strongly suggesting that this compact structure likely
represents a conformation of the protein in solution. However, the
helix-turn-helix motifs display high temperature factors or even
partial disorder, and are engaged in extensive crystal contacts,
suggesting the coexistence of alternative conformational states in
solution characterized by flexible DBDs. In that sense, in one
protomer of the crystal form 2 (Table 1) both helix aL and its
associated DBD are highly flexible and could not be modeled,
suggesting a marginal stability of the observed quaternary
arrangement. Moreover, the first visible residues of this same
monomer (positions 72–77, connecting helix aL with the first b-
strand of the EBD) adopt a conformation that differs from that
observed in the other ligand-free or malonyl-CoA-bound proto-
Figure 2. SaFapR-DNA interactions. (A) Promoter recognition by the SaFapR DNA-binding domain. Protein residues making hydrogen-bonding
interactions with specific bases (Gln41, Arg56) or with the phosphate backbone are indicated. The DNA double-helix is depicted in solvent accessible
surface representation and colored according to the mapped electrostatic potential (negative charge in red, positive in blue). (B) Schematic
representation of protein-DNA hydrogen-bonding interactions for one FapR homodimer. Protein residues involved in base-specific hydrogen-
bonding interactions are colored red and those involved in phosphate hydrogen-bonding interactions are blue; the specifically recognized bases are
orange. In the crystal structure, the DNA duplex exists 50:50 in the two possible orientations, and the figure shows the 59 to 39 sequence covering the
17 bp palindromic sequence (28 to +8) conserved in promoters of the fap regulon. The non-crystallographic two-fold axis relating the two FapR
homodimers in the crystal structure is indicated by the green arrow. (C) Schematic view of the DNA conformation within the FapR–DNA complex.
Each base pair is represented by a single block, and the dark-shaded side indicates the minor groove. The actual base-step parameters are reported in
Table S2.
doi:10.1371/journal.ppat.1003108.g002
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mers, but resembles that found for one subunit of the asymmetric
DNA-bound form of the repressor (Fig. 4B).
Ligand-induced structural transition
The structure of SaFapR in complex with the DNA operator
revealed a strikingly different overall conformation of the
protein, compared to those of the ligand-free and the effector-
bound repressor. As highlighted by the crystal structures
described above, the transitional switch between the relaxed
(DNA-bound) and tense (malonyl-CoA-bound) forms of the
repressor involves a large-scale structural rearrangement
(Fig. 5). The amphipathic helix aL, whose hydrophobic face
binds to the protein core in the tense state (Fig. 5A),
structurally dissociates and moves .30 A˚ to interact with the
same helix from the other protomer and with DNA in the
relaxed state (Fig. 5B). This DNA-driven process requires
partial unwinding of the linker helix aL and the solvent-
exposure of hydrophobic side-chains from the EBD (Leu82,
Ile83, Val85, Ile94, Val123) and from the loop immediately
following helix aL (Ile70, Phe78) in both protomers. Such a
substantial conformational rearrangement between the tense
and relaxed states (Fig. 5C) contrasts with the more subtle
structural changes observed for other well-studied bacterial
classes of allosteric transcriptional regulators such as the
tetracycline [29] or lactose [30] repressors, illustrating that
specific physiological responses can be achieved by a variety of
mechanisms.
Disruption of membrane lipid homeostasis is lethal for S.
aureus
Bacterial FASII has been identified as a promising target for
antibacterial drug discovery. Nevertheless, Brinster et al [31]
have questioned the feasibility of this approach in Gram-positive
pathogens based on the finding that FASII is not essential in
Streptococcus agalactiae if the bacterium is supplemented with fatty
acids or human serum. This controversy was recently clarified by
Parsons et al [32], who showed that externally added fatty acids
downregulate the activity of the acetyl-CoA carboxylase in some
Gram-positive pathogens, such as Streptococcus pneumoniae. This
biochemical mechanism suppresses the malonyl-CoA levels
allowing fatty acid supplements to replace endogenous fatty
acids completely, thus rescuing bacterial FASII inhibition. In S.
aureus, this feed-back regulatory mechanism is not present [32]
and thus external fatty acids do not circumvent the treatment of
this bacterium with FASII inhibitors. These results and the
regulatory properties of the acc genes led the authors to propose
that pathogens containing FapR would likely be sensitive to
FASII inhibitors, regardless of the addition of external fatty acids
[32]. These considerations prompted us to test if structure-based
mutations predicted to disrupt the SaFapR-malonyl-CoA inter-
action are lethal for S. aureus even in the presence of extracellular
fatty acids. To this end, based on the structural information and
on our previous work [20], we substituted Arg110 by alanine to
disrupt the key interaction with the malonyl carboxylate, and
introduced a double substitution (Gly111Val, Leu132Trp) to
Figure 3. Overall structures of the malonyl-CoA-bound forms of SaFapR. (A) Cartoon showing the structure of the SaFapR-malonyl-CoA
homodimer in two different views. The first protomer is shown in green; the second protomer is shown in blue (the helix-turn-helix motif - in dark
blue - was partially visible in the electron density map but was not included in the final model due to high protein mobility). Bound malonyl-CoA is
shown in surface representation. (B) Closer view of the interactions between the central hot-dog fold (electrostatic surface representation) and the
linker helix (green). Hydrophobic side chains involved in inter-domain interactions are labeled. (C) Electron density map of malonyl-CoA and protein-
ligand interactions. Hydrogen bonds are indicated by dashed lines and protein residues from each protomer are colored green and yellow
respectively.
doi:10.1371/journal.ppat.1003108.g003
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block the ligand-binding tunnel that accommodates the phos-
phopantetheine moiety in the repressor-effector complex
(Fig. 3C). These mutants were expected to retain their DNA-
binding capacity and to permanently repress the expression of
the fap regulon, independently of the metabolic conditions. To
test this prediction we engineered S. aureus fapR null mutants to
produce the protein variants in response to an inducer (IPTG).
IPTG-induced expression of SaFapRR110A caused a small drop
in cell viability (data not shown), while cells expressing
SaFapRG111V,L132W failed to grow (Fig. 6). A variety of fatty
acids, including oleic acid, a common mammalian fatty acid, and
anteiso saturated fatty acids, the most abundant acyl chains
found in S. aureus phospholipids were unable to overcome the
growth inhibition caused by the expression of the superrepressor
SaFapRG111V,L132W in S. aureus (Fig. 6). These results clearly
show that disruption of the membrane lipid homeostasis mimics
the effects of FASII inhibitors in S. aureus strongly supporting the
notion that exogenous fatty acids cannot replace the endoge-
nously produced acyl chain in this bacterium [32].
Discussion
The structures of SaFapR, in three relevant states of its
regulation cycle, uncover a complex biological switch, character-
ized by completely different protein-protein interactions involving
in all cases the linker helix aL and so leading to a distinct
quaternary arrangement.for the tense and relaxed states of the
repressor (Fig. 5). Similarly to other homodimeric proteins studied
by single-molecule or NMR relaxation approaches [33,34], our
crystallographic studies suggest that the two conformational states
of SaFapR (i.e. with EBD-bound or EBD-detached DBDs) can be
populated in the ligand-free repressor species. Thus, a higher
cellular concentration of malonyl-CoA would not only trigger the
conformational changes that disrupt the SaFapR-operator com-
plex [20], but would also promote the dynamic shift of the ligand-
free repressor population towards the tense state.
Our results highlight the ability of FapR to monitor the levels of
malonyl-CoA and appropriately tune gene expression to control
lipid metabolism, ensuring that the phospholipid biosynthetic
Figure 4. The structures of the SaFapR homodimer in the absence of ligands display distinctive features of either the malonyl-CoA-
bound or the DNA-bound forms of the repressor. (A) Structural superposition of the ligand-free repressor in two different crystal forms (green
and cyan) with the malonyl-CoA-bound form (yellow), revealing a similar quaternary organization. Bound malonyl-CoA is shown as solid spheres.
Note that helix aL and its attached DBD are flexible (not modeled) in one monomer of the ligand-free repressor (in cyan, at right). (B) Superposition of
this same monomer (magenta) with an equivalent subunit from the malonyl-CoA-bound (cyan) and the DNA-bound (yellow) forms of the repressor.
The EBD region (grey molecular surface) is identical for all three monomers. The loop connecting helix aL with the first b-strand of the EBD in the
ligand-free subunit (residues 72–76) has the same conformation as observed in the DNA-bound structure. In both panels, the arrow indicates the first
visible residue (Ser72) of the subunit with a disordered helix aL.
doi:10.1371/journal.ppat.1003108.g004
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pathway will be supplied with appropriate levels of fatty acids
either synthesized endogenously or incorporated from the
environment. Bacterial FASII is a target actively pursued by
several research groups to control bacterial pathogens [35]. A
controversy surrounding FASII as a suitable antibiotic target for S.
aureus was based on the ability of this pathogen to incorporate
extracellular fatty acids [36]. This apparent discrepancy was
recently clarified by showing that although exogenous fatty acids
indeed are incorporated by S. aureus, following its conversion to
acyl-ACP, they cannot deplete the generation of malonyl-CoA and
malonyl-ACP [32]. Thus, these fatty acid intermediates release
FapR from its binding sites [28] and are used by FASII to initiate
new acyl chains. Thus, when a FASII inhibitor is deployed against
S. aureus, the initiation of new acyl chains continues leading to
depletion of ACP, which is correlated with diminished exogenous
fatty acids incorporation into phospholipids [32]. Strikingly,
SaFapR, not only control the expression of the FASII pathway,
but also regulate the expression of key enzymes required for
phospholipid synthesis such as PlsX and PlsC [18,37]. Most of the
Gram-positive pathogens rely on the PlsX/PlsY system to initiate
phospholipid synthesis by converting acyl-ACP to acyl-P04 by
PlsX followed by the transfer of the fatty acid to the 1 position of
glycerol-PO4 by the PlsY acyltransferase [37,38]. A strength of
targeting these steps in lipid synthesis is that acyltransferases
inhibition cannot be circumvented by supplementation with
extracellular fatty acids. Thus, targeting of lipid synthesis with
compounds that block the expression of PlsX in S. aureus cannot be
ignored, specially taking into account that it has been reported that
extracellular fatty acids increase the MIC for FASII inhibitors in
this important pathogen. [32,39]. In this sense, the unique mode of
action of FapR and our encouraging in vivo results validate lipid
homeostasis as a promising target for new antibacterial drug
discovery in Gram-positive bacteria.
Conserved in many Gram-positive bacteria, FapR is a paradigm
of a feed-forward-controlled lipid transcriptional regulator. In
other characterized bacterial lipid regulators it is the long acyl-
chain end products of the FASII pathway that act as feedback
ligands of lipid transcriptional regulators [40]. The effector-
Figure 5. The transitional switch between the relaxed and tense states of the repressor involves a significant rearrangement of the
DBDs. (A) SaFapR in complex with malonyl-CoA (shown in stick representation), tense state. (B) SaFapR in complex with DNA, relaxed state in which
the amphipathic helix aL from each protomer associates with each other. (C) Superposition of the two conformational states of the repressor
illustrating the structural transition. Solvent accessible surfaces are shown in transparent to highlight the DNA-induced dissociation of the invariant
effector-binding domain from the DBDs. The molecules are shown in light (relaxed) and dark (tense) grey, except for the helices from one DBD
(colored).
doi:10.1371/journal.ppat.1003108.g005
Figure 6. Expression of the SaFapRG11V, L132W superrepresor is lethal for S. aureus and fatty acid supplementation cannot overcome
growth inhibition. The figure shows the growth of strain RN4220DfapR expressing SaFapRG11V, L132W (REH117) or SaFapRWT (REH118) under the
tight inducible PspacOid promoter on THA plates in the absence or presence of 10 mM IPTG. Identical results were obtained for strain REH117
growing in 10 mM IPTG when supplemented with either Tween80 (0.1%) or 500 mM of the following fatty acids: palmitic acid (16:0), oleic acid (18:1),
16:0+18:1, anteiso 17:0 (a17:0), a15:0+a17:0, or 18:0+a17:0.
doi:10.1371/journal.ppat.1003108.g006
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binding domains of these proteins, such as E. coli FadR [12] or the
TetR-like P. aeruginosa DesT [17], frequently display an a-helical
structure with a loose specificity for long-chain acyl-CoA
molecules, possibly because the permissive nature of helix-helix
interactions provide a suitable platform to evolve a binding site for
fatty acid molecules of varying lengths. In contrast, a high effector-
binding specificity is required for the feed-forward regulation
mechanism of the FapR repressor family [19], which entails the
recognition of an upstream biosynthetic intermediate, namely the
product of the first committed step in fatty acid biosynthesis. This
high specificity is achieved in SaFapR by caging the charged
malonyl group inside a relatively stiff internal binding pocket, and
may be the reason why the hot-dog fold was recruited for this
function. Nevertheless, it could be expected that, in organisms
using the FapR pathway, a complementary feed-back regulatory
loop should also operate at a biochemical level, for instance by
controlling the synthesis of malonyl-CoA [37]. This would imply
that lipid homeostasis in FapR-containing bacteria would be
exquisitely regulated by feed-back and feed-forward mechanisms,
as it is indeed the case in higher organisms ranging from
Caenorhabditis elegans to humans [41].
Materials and Methods
In vivo studies
In frame fapR deletion mutants of S. aureus strains RN4220 and
HG001 [42], RN4220DfapR and HG001DfapR respectively, were
constructed and the expression level of the plsX and fabH genes,
belonging to the fap regulon, was analyzed by real time PCR as
described in Text S1. To evaluate the activity of the S. aureus
repressor in B. subtilis, we used the DfapR mutant strain GS416 that
contains a PfabHB-lacZ reporter fusion and expressed S. aureus fapR
from the xylose inducible PxylA promoter (for further details see
Text S1).
Mutants SaFapRR110A and SaFapRG111V,L132W, impaired in
malonyl-CoA binding were obtained by site-directed mutagenesis
using S. aureus RN4220 genomic DNA as template, mutagenic
oligonucleotides and overlap-extension PCR. The replicative
vector pOS1 [43] and the tight IPTG-regulated PspacOid promoter
from pMUTIN4 were used for ectopical expression of fapR alleles
in RN4220DfapR (see Text S1 for details). S. aureus transformants
were selected in THA plates supplemented with cloramphenicol
(5 mg/ml) and expression of fapR alleles was achieved by addition
of 10 mM IPTG. To evaluate the effect of an external source of
fatty acids THA plates were supplemented with 500 mM of the
stated fatty acids or 0.1% Tween80 (Fig. 6).
Protein expression and purification
The S. aureus fapR gene was cloned into the pET15b vector
(Novagen) as described in Text S1 and expressed in E. coli BL21/
pLysS. Bacterial cultures were grown in LB supplemented with
ampiciline 100 mg/ml and chloramphenicol 10 mg/ml at 37uC
until OD600 0.6. Expression was induced with 0.5 mM IPTG at
20uC for 17 hours. Cells were harvested by centrifugation at 4uC,
and protein-containing fractions from a Ni2+-affinity chromatog-
raphy on a HisTrap column (GE Healthcare) were dialyzed
overnight against an excess volume of 50 mM Tris-HCl pH 7.6,
300 mM NaCl and 1 mM DTT at room temperature, in the
presence of a 1/40 (w/w) ratio of His-tagged TEV protease. After
dialysis, a second affinity chromatography step was performed in
the presence of 20 mM imidazole, the flow through was
concentrated and injected into a HiLoad 16/60 Superdex 75
prep grade column (GE Healthcare) equilibrated with 50 mM
Tris-HCl, pH 7.6, and 300 mM NaCl. After gel filtration SaFapR
was dialyzed at room temperature against 20 mM Tris-HCl
pH 7.6 and 50 mM NaCl, concentrated to 15 mg/ml and stored
in aliquots at 280uC for further use. Selenomethionine (SeMet)-
labeled SaFapR was obtained using the E. coli strain B834
(Novagen) grown in M9 medium containing 0.2 g/l selenomethi-
onine and purified as above.
Crystallographic studies
Crystals of the repressor and its complexes with the effector and
operator molecules were obtained as described in Text S1. All
diffraction datasets were collected from single crystals at 100 K
using synchrotron radiation at beamlines ID14.4 and ID29
(European Synchrotron Radiation Facility, Grenoble, France) or
Proxima 1 (SOLEIL, Saint-Aubin, France). Data were processed
with either XDS [44] or iMosflm [45] and scaled with XSCALE
from the XDS package or SCALA from the CCP4 suite [46]. The
crystal structures of SaFapR alone and its complex with malonyl-
CoA were solved by molecular replacement methods using the
program AMoRe [47] and the effector-binding domain of B.
subtilis FapR (PDB entry 2F41) as the search model. In all cases,
the missing DNA-binding domains were manually traced from
sigma A-weighted Fourier difference maps. The structure of the
repressor-operator complex was solved by a combination of
molecular replacement and single-wavelength anomalous diffrac-
tion (SAD) techniques using SeMet-labeled SaFapR. The selenium
substructure was determined with the program SHELXD [48]
and further refined with the program SHARP [49]. Structures
were refined with REFMAC5 [50] or BUSTER [51] (for the
SeMet-labeled protein-DNA complex) using a TLS model and
non-crystallographic symmetry restraints when present, alternated
with manual rebuilding with COOT [52]. Models were validated
through the MolProbity server [53]. Data collection and
refinement statistics are reported in Table 1. Graphic figures
were generated and rendered with programs Pymol [54] and
3DNA [55].
Isothermal titration calorimetry
ITC experiments were performed using the high precision VP-
ITC system (MicroCal Inc., MA) and quantified with the Origin7
software provided by the manufacturer. All molecules were
dissolved in 50 mM TrisHCl, pH 8, 150 mM NaCl and the
binding enthalpies were measured by injecting the SaFapR
solution into the calorimetric cell containing the 40 bp DNA
solution. Heat signals were corrected for the heats of dilution and
normalized to the amount of compound injected. Complementary
DNA strands were heated to 90uC and annealed by a stepwise
decrease to 25uC followed by 30 min on ice prior to use; DNA
concentration was determined by absorption at 260 nm.
Accession codes
Crystallographic coordinates and structure factors were depos-
ited in the Protein Data Bank, with accession codes 4a0x, 4a0y,
4a0z and 4a12.
Supporting Information
Figure S1 Fatty acid synthesis and phospholipid initiation steps
in Bacillus subtilis. The FabH condensing enzymes initiates the
cycles of fatty acid elongation by condensation of acyl-CoA
primers with malonyl-ACP (3a). The resultant b-ketoester is
reduced by the b-ketoacyl-ACP reductase (4). Then, the b-
hydroxyacyl-ACP is dehydrated to the trans-2 unsaturated acyl-
ACP by b-hydroxyacyl-ACP dehydrase (5), which is finally
reduced by enoyl reductase (6). Subsequent rounds of elongation
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are initiated by the elongation-condensing enzyme FabF (3b) to
generate an acyl-ACP two carbons longer than the original acyl-
ACP at the end of each cycle. The long chain acyl-ACP end
products of fatty acid synthesis are transacylated in three steps to
glycerolphosphate, to generate phosphatidic acid (PA), a key
intermediate in the synthesis of phospholipids. First, PlsX catalyzes
the synthesis of fatty acylphosphate from acyl-ACP (7); then, PlsY
transfers the fatty acid from the activated acyl intermediate to the
1-position of glycerol-3P (8) and finally, lyso-PA is acylated to PA
by PlsC (9). Malonyl-CoA is generated from acetyl-CoA by acetyl-
CoA carboxylase (1) and then is transferred to ACP by malonyl-
CoA transacylase (2). Expression of the genes surrounded by
shaded ellipses is repressed by FapR, whose activity is, in turn,
antagonized by malonyl-CoA (enclosed in a rectangular box). R
denotes the terminal group of branched-chain or straight-chain
fatty acids.
(TIF)
Figure S2 Effect of malonyl-CoA and short-chain acyl-CoA
thioesters on binding of SaFapR to PfapR. (A) Electrophoretic shift
assay showing the binding of SaFapR to PfapR. Increasing amounts
of SaFapR were incubated with 30 nM of double strand PfapR
probe (left panel) or non-specific DNA (right panel). (B) Effect of
malonyl-CoA on SaFapR binding to PfapR. The gel mobility shift
assay was performed with two concentrations of SaFapR (100 nM
or 500 nM), previously incubated at different concentrations of
malonyl-CoA for 15 min at room temperature followed by
addition of the probe to the SaFapR-malonyl-CoA complex. (c)
Effect of malonyl-CoA analogs on SaFapR binding to PfapR.
SaFapR (200 nM) was previously incubated, as described in b,
with malonyl-CoA (lanes 3 and 4), acetyl-CoA (lanes 5 and 6),
propionyl-CoA (lanes 7 and 8) or succinyl-CoA (lanes 9 and 10)
before adding the PfapR probe to the reaction mixture. Gels were
stained with SYBR GREEN and scanned at 530 nm.
(TIF)
Figure S3 Conservation of FapR function in S. aureus. (A) RT-
PCR results showing the expression of two genes from the fap
regulon (plsX, fabH) in two different strains (RN4220, HG001).
Relative levels of transcripts were measured by qRT-PCR.
Expression levels were normalized using 16S RNA as an internal
standard and are indicated as an n-fold change, expressed as the
means and standard deviations of quadruplicate experiments. (B)
SaFapR complements a B. subtilis fapR null strain. Cultures of
strains GS413 (squares; DfapR, PfabHB-lacZ, amyE::spc), GS373
(circles; DfapR, PfabHB-lacZ, amyE::Pxyl-BsfapR:spc) and GS416
(triangles; DfapR, PfabHB-lacZ, amyE::Pxyl-SafapR:spc) were incu-
bated in LB medium in the presence of xylose 0.1% (w/v) at 37uC
and growth was monitored. Samples were removed to assay ß-
galactosidase-specific activity at the indicated times. A single
experiment representative of three repeats is shown. Solid lines, ß-
galactosidase-specific activity; dotted lines, OD525.
(TIF)
Figure S4 Alignment of the promoter regions of the genes and
operons regulated by FapR. The -10 motifs of RNA polymerase
binding boxes are indicated with rectangles. The conserved
inverted repeat sequence is shaded and a consensus sequence is
indicated at the bottom line. Bases are numbered related to the
first base of the translation initiation codon.
(TIF)
Figure S5 Different roles of the amphipatic linker helix aL in
stabilizing the SaFapR-DNA and SaFapR-malonyl-CoA complex-
es. (A) Close view of the SaFapR-DNA complex. (B) Close view of
the interactions between the EBD, the linker helix (green) and the
DBD in the structure of the SaFapR-malonyl-CoA complex. In
both cases, hydrophobic and hydrophilic side chains involved in
inter-domain interactions are labeled. Malonyl-CoA binding
triggers significant conformational changes in three main regions
of the repressor: the connecting loop aL - b1, the amphipathic
helix aL and the DBD. The side-chain of Arg110 from the EBD
makes a key hydrogen bond with the main-chain carbonyl group
of Glu779 in the loop. In addition, the Glu779 side-chain is
hydrogen bonded to the main chain of His104 from the EBD,
facilitating the formation of a strong salt bridge between the side-
chains of Lys105 and Glu749. The Ser102 side-chain makes a
strong hydrogen bond with Val123, whereas its main chain
interacts through hydrogen bonding networks with Ser72, Pro129
and a water molecule. Furthermore, the main-chain of Gln69
makes an electrostatic interaction with the side-chain of Lys127.
These newly formed electrostatic/hydrogen-bond interactions
allow the connecting loop aL - b1 to firmly interact with the core
of the EBD. As a consequence, the amphipathic helix aL forms
now an extended hydrophobic interface (Leu55, Ile59 and Val62),
with both b1 (Ile83) and b2 (Ile94) strands of the EBD, and the
a1–a2 connecting loop of the DBD (Pro25, Phe26 and Thr28).
This structural arrangement is further stabilized by key electro-
static interactions. Arg56 makes a salt bridge with Asp96 located at
the top of b2 and the side-chain of Asn66 makes a hydrogen bond
with the carbonyl group of the main-chain of Leu82 on the b1
strand. Moreover, the side-chain of Tyr67 is oriented towards a
hydrophobic pocket including residues Leu82, Val85 from b1, and
Ile70, Ile73 and Phe78 from the connecting loop aL - b1.
(TIF)
Figure S6 Sequence alignment of FapR. Amino acid sequence
and secondary structure elements (green for DBD, pink for EBD)
of SaFapR. Residues that interact with the pantetheine group of
malonyl-CoA and with DNA are underlined by open and closed
circles, respectively. Wavy lines indicate disordered regions in the
crystal structure. Colored amino acid positions indicate highly
conserved residues in non-redundant FapR sequences from 67
different bacterial species (yellow, .80%; orange, .95%).
(TIF)
Figure S7 Structural superposition of the BsFapRD43-malonyl-
CoA and SaFapR-malonyl-CoA complexes. Although the orien-
tation of helix aL is different (it is involved in crystal packing
contacts in BsFapRD43), binding of malonyl-CoA promotes the
same conformation of the loop connecting this helix with the first
b-strand of the EBD.
(TIF)
Table S1 The fap regulon in B. subtilis and S. aureus.
(DOC)
Table S2 Local base-pair step parameters of the DNA in
complex with SaFapR.
(DOC)
Table S3 Oligonucleotides used in this work.
(DOC)
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